Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort ascending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort ascending Functional Area Date Posted
Allergy Territory Account Specialist - Chicago, IL (South) - Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 11, 2024
Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Sep 11, 2024
Global R&D QMS Senior Specialist Hyderabad (Office) India Development Innovative Medicines Quality Sep 11, 2024
Portfolio Account Specialist (Immunology, Part Time) Western Australia (WA) Australia International Innovative Medicines Sales Sep 11, 2024
Portfolio Account Specialist (Immunology, VIC West) Victoria (VIC) Australia International Innovative Medicines Sales Sep 11, 2024
Senior Regulatory Affairs Manager Vietnam Vietnam Development Innovative Medicines Research & Development Oct 08, 2024
Medical Sales Representative (Mornington Peninsula) Victoria (VIC) Australia International Innovative Medicines Sales Sep 11, 2024
Elektrotechniker (m/f/d), Kundl, Tirol Kundl Austria Operations Innovative Medicines Technical Operations Sep 12, 2024
Techniker/Mechatroniker/Mechaniker/Elektriker/Schlosser (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Technical Operations Sep 12, 2024
Allergy-Territory Account Specialist – Tucson, AZ – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 12, 2024
Head, Clinical Development Strategy & Integration Lead Basel (City) Switzerland Development Innovative Medicines Research & Development Sep 12, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 12, 2024
Associate Director- Clinical Data Standards Mumbai (Office) India Development Innovative Medicines Research & Development Sep 13, 2024
QA Site Manager & pharmacien adjoint - Saint-Genis-Pouilly H/F St-Genis-Prod France Operations Innovative Medicines Quality Sep 13, 2024
Public Affairs Manager Ankara Gimat Turkey International Innovative Medicines Communications & Public Affairs Sep 13, 2024
QC Analyst/ Specialist Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 13, 2024
Strategy and Operations Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 13, 2024
Allergy-Territory Account Specialist – Toldeo, OH – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 13, 2024
Vodja investicijskih projektov (m/ž/d) / Engineering Project Manager (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Sep 13, 2024
349145BR - Director, Channel Enablement and Optimization Governance East Hanover USA US Innovative Medicines Marketing Sep 13, 2024
Lead Principal CDS Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Sep 15, 2024
Medical Lead Oncology Mumbai (Head Office) India International Innovative Medicines Research & Development Sep 16, 2024
Senior Global Risk Management Plan Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Sep 16, 2024
Principal Biostatistician Home Worker United Kingdom Development Innovative Medicines Research & Development Sep 17, 2024
Director Quantitative Safety Scientist Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Sep 17, 2024
Medical Science Liaison (MSL), Czech Republic Prague Czech Republic International Innovative Medicines Research & Development Sep 27, 2024
Allergy- Territory Account Specialist – San Francisco, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 27, 2024
Field Sales Leader, Oncology (Scotland, Northern Ireland & North East England) Field Force (Scotland) United Kingdom International Innovative Medicines Sales Sep 27, 2024
(高级)医药代表 /(资深)产品专员 Xian (Shanxi Province) China International Innovative Medicines Sales Sep 29, 2024
Medical Science Liaison, Immunology Chongqing (Chongqing Province) China International Innovative Medicines Research & Development Sep 30, 2024
Global Labeling Compliance & Project Lead London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 30, 2024
Global Labelling Systems & Project Lead London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 30, 2024
Innovation Manager Hyderabad (Office) India Operations Innovative Medicines Quality Sep 30, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Sep 30, 2024
Clinical Development Medical Director Basel (City) Switzerland Development Innovative Medicines Research & Development Sep 30, 2024
Senior IP Specialist / Patent Attorney Basel (City) Switzerland Legal Innovative Medicines Legal & Intellectual Property & Compl. Sep 30, 2024
Allergy- Territory Account Specialist – Detroit, MI – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 30, 2024
Senior Market Access Manager New South Wales (NSW) Australia International Innovative Medicines Market Access Sep 30, 2024
Territory Business Executive Orissa India International Innovative Medicines Sales Sep 30, 2024
Automation Coordinator Puurs Belgium Operations Innovative Medicines Technical Operations Oct 01, 2024
Next Generation Scientist 2025 Basel (City) Switzerland Biomedical Research Innovative Medicines Others Oct 01, 2024
Regional Business Manager Bangalore (Office) India International Innovative Medicines Sales Oct 01, 2024
Zonal Business Manager Delhi (Office) India International Innovative Medicines Sales Oct 01, 2024
AS&T Expert (Micro) Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 01, 2024
Zonal Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Assam India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Orissa India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only